CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
Two samples on each of the three sites (pharynx, rectum, urine)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03568695
NCT03568695N/ACompleted

Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction After Pooling Pharyngeal, Anorectal and Urinary Samples, in Men Who Have Sex With Men

Centre Hospitalier Régional d'Orléans·interventional·Posted Jun 26, 2018·Updated Sep 1, 2020

In Brief

A clinical study evaluating Two samples on each of the three sites (pharynx, rectum, urine) for Chlamydia Trachomatis Infection and 4 related conditions. Completed, enrolled 166 participants across 5 sites.

Detailed Summary

This study aims to compare the sensitivity of detecting Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium by real-time multiplex PCR in a pooled analysis (i.e. gathering pharyngeal, anorectal and urinary samples) versus the standard of care (where a real-time multiplex PCR is made in each of the three samples).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 26, 2018
Enrollment StartJun 29, 2018
Primary CompletionJun 16, 2020
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 8.0 years ago

Interventions

Two samples on each of the three sites (pharynx, rectum, urine)other

two new samples on each of the three sites (pharynx, rectum, urine) which will make it possible to compare the difference of sensitivity between real-time multiplex PCR from pools of 3 samples and the usual technique .